Cognitive function, quality of life, and survival outcomes in patients with lower grade gliomas treated with proton radiation therapy: A phase II study
Proton therapy for LGG can offer effective disease control with modest long-term toxicity. These findings support its use as a standard radiation modality and highlight the need for comparative trials with photon therapy.
Authors
- KK Oh
- J. Slater (ORCID: https://orcid.org/0000-0002-3572-1241)
- Alexander T. Faje (ORCID: https://orcid.org/0000-0002-4092-5409)
- H. Shih
- Irene S. Wang
- Nicholas A. Tritos (ORCID: https://orcid.org/0000-0001-8867-607X)
- Thomas Botticello
- William T. Curry (ORCID: https://orcid.org/0000-0002-8036-1847)
- Brian V. Nahed (ORCID: https://orcid.org/0000-0001-8537-106X)
- Janet C. Sherman (ORCID: https://orcid.org/0000-0001-9782-3158)
- Barbara C. Fullerton
- Jorg Dietrich
- Daniel P Cahill
- Lisa B Nachtigall
- Michael W Parsons
- Isabel C Arrillaga-Romany
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Loma Linda University Medical Center (US)
- Harvard University (US)
- Loma Linda University (US)
- Massachusetts General Hospital (US)
- Global Cancer Institute (US)
- Center for Cancer Research (US)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1093/neuonc/noag008
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00